NCT07142798View on ClinicalTrials.gov

to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection

NAEnrolling by invitationINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 26, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
HELICOBACTER PYLORI INFECTIONS
Interventions
DRUG

Bismuth amoxilillin potassium

vonoprazan 20mg， Twice a day amoxicillin 750mg，Four times a day tripotassium dicitrate bismuthate 300mg，Four times a day for 14 days

Trial Locations (1)

807

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
collaborator

An-Nan Hospital, China Medical University

OTHER

lead

Kaohsiung Medical University

OTHER